Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Clovis Oncology (CLVS) News Today

Clovis Oncology logo
Clovis Chamber names new Retail Rockstar
Cancer Horoscope
City of Clovis hosts tree lighting ceremony
Clovis East High School
Analysts Holding As Pfizer Waits On Two Phase 3 Studies
Analysts Holding As Pfizer Waits On Two Phase 3 Studies (CLVS)
Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value.
CLVS.O
CLVSQ Clovis Oncology, Inc.
Clovis Oncology
Boulder drugmaker Clovis Oncology files for bankruptcy
Cancer Focused Clovis Oncology Files For Bankruptcy
U.S. drugmaker Clovis files for Chapter 11 bankruptcy
Dear CLVS Stock Fans, Get Ready for a Bankruptcy Filing
Clovis Oncology (CLVS) Stock Pops After Bankruptcy Warning
Why Is Clovis Oncology (CLVS) Stock Down 72% Today?
Get Clovis Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLVS and its competitors with MarketBeat's FREE daily newsletter.

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

CLVS Media Mentions By Week

CLVS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLVS
News Sentiment

0.00

0.59

Average
Medical
News Sentiment

CLVS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLVS Articles
This Week

0

0

CLVS Articles
Average Week

Get Clovis Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLVS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CLVS) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners